MARKET

ICPT

ICPT

Intercept
NASDAQ

Real-time Quotes | Nasdaq Last Sale

85.55
+2.55
+3.07%
Closed 16:21 11/19 EST
OPEN
83.53
PREV CLOSE
83.01
HIGH
85.84
LOW
83.14
VOLUME
442.12K
TURNOVER
--
52 WEEK HIGH
131.87
52 WEEK LOW
56.76
MARKET CAP
2.80B
P/E (TTM)
-7.8692
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ICPT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ICPT News

  • Edited Transcript of ICPT earnings conference call or presentation 5-Nov-19 1:30pm GMT
  • Thomson Reuters StreetEvents.11/13 04:12
  • UBS Maintains Buy on Intercept Pharmaceuticals, Lowers Price Target to $135
  • Benzinga.11/12 12:50
  • 20 Stocks That Could Double Your Money in 2020
  • MotleyFool.com.11/11 11:06
  • Better Buy: Intercept Pharmaceuticals or Genfit?
  • MotleyFool.com.11/10 13:00

More

Industry

Biotechnology & Medical Research
+2.16%
Pharmaceuticals & Medical Research
+0.78%

Hot Stocks

Name
Price
%Change

About ICPT

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). In addition to OCA, it is developing other bile acid analog compounds targeting FXR and a second dedicated bile acid receptor called TGR5, which is a target of interest for the treatment of type 2 diabetes and other gastrointestinal indications. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.
More

Webull offers Intercept Pharmaceuticals Inc (ICPT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.